These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5296417)

  • 21. [Clinical significance of determining the sensitivity of dysentery microbes to antibiotics].
    Bochorishvili VG; Gegiia TN; Bibineĭshvili MV; Giorgobiani ES; Ukleba KD
    Sov Med; 1972 May; 35(5):63-6. PubMed ID: 5042690
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug-resistant dysentery].
    Suzuki Y
    Naika; 1970 Jun; 25(6):1155-6. PubMed ID: 5431257
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial susceptibilities of Shigella species isolated in Ontario in 1990.
    Harnett N
    Can Dis Wkly Rep; 1991 Dec; 17(50):275-7. PubMed ID: 1843660
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience in the treatment of dysentery].
    Ribiczey P; Beke G
    Orv Hetil; 1974 Mar; 115(12):677-9. PubMed ID: 4361059
    [No Abstract]   [Full Text] [Related]  

  • 25. Multidrug resistant Shigella infections in children.
    Patwari AK
    J Diarrhoeal Dis Res; 1994 Sep; 12(3):182-6. PubMed ID: 7868824
    [No Abstract]   [Full Text] [Related]  

  • 26. Tennessee Shigella update.
    Jones TF; Hanna S
    Tenn Med; 2006 Jan; 99(1):645-6. PubMed ID: 16475596
    [No Abstract]   [Full Text] [Related]  

  • 27. [Shigellosis in Tananarive (Madagascar). II : Bacteriologic and therapeutic features (author's transl)].
    Capdeville P; Dion P; Pecarrere JL; Valmary J; Coignard A; Boudon A; Delprat J
    Med Trop (Mars); 1979; 39(4):453-6. PubMed ID: 395407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in antimicrobial resistance of Shigella species isolated from children with acute diarrhea.
    Niyogi SK; Dutta P; Mitra U
    Indian Pediatr; 2000 Mar; 37(3):339-41. PubMed ID: 10750086
    [No Abstract]   [Full Text] [Related]  

  • 29. Nalidixic acid in resistant shigella infection.
    Agrawal ML; Mukherjee SP; Prasad SS
    J Assoc Physicians India; 1987 May; 35(5):390. PubMed ID: 3693298
    [No Abstract]   [Full Text] [Related]  

  • 30. Epicillin in the treatment of shigellosis and salmonellosis.
    Landa L
    Curr Ther Res Clin Exp; 1971 Oct; 13(10):654-9. PubMed ID: 4338475
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of different sensitivity of Shigella to chlortetracycline on the therapeutic effect of this antibiotic].
    Mokrov BA
    Antibiotiki; 1967 Mar; 12(3):230-5. PubMed ID: 5593956
    [No Abstract]   [Full Text] [Related]  

  • 32. [The adaptation of therapeutic standards as a function of antibiotic sensitivity of strains of Shigella spp. isolated in Rwanda in 1997].
    Aldighieri S; Kamoso P; Suermondt G; Rugimbanya P; Ngabonziza C; Kayirangwa E
    Med Trop (Mars); 1997; 57(4):412. PubMed ID: 9612786
    [No Abstract]   [Full Text] [Related]  

  • 33. Bactericidal action of urea on shigella.
    Nakamura M
    Rocky Mt Med J; 1968 May; 65(5):69-71. PubMed ID: 5652646
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the action of polymyxin M on dysentery bcteria in experimental and clinical conditions according to data from Gomel].
    Khodalevich IV
    Antibiotiki; 1967 Feb; 12(2):163-6. PubMed ID: 4298088
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the resistance of shigellae to antibiotics in the course of acute dysentery in children].
    Dvorský K; Mirovský J
    Zentralbl Bakteriol Orig; 1966 Oct; 201(2):223-34. PubMed ID: 4296821
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of bacillary dysentery with Hetacillin (BL-P 804). Preliminary report].
    Totani T; Yamada Y; Amano F
    J Antibiot B; 1967 Apr; 20(2):108-10. PubMed ID: 4861541
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiological and clinical characteristics of shigellosis in rural Bangladesh.
    Baqui AH; Zaman K; Yunus M; Mitra AK; Hossain KM; Banu H
    J Diarrhoeal Dis Res; 1988 Mar; 6(1):21-8. PubMed ID: 3251937
    [No Abstract]   [Full Text] [Related]  

  • 38. International note. Antibiotics in the management of shigellosis.
    Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.